BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6790915)

  • 21. [Cost-price index of services of a pathological institute].
    Hjorth L; Nielsen VT; Steffensen A; Eierdal H
    Ugeskr Laeger; 1982 Sep; 144(38):2811-6. PubMed ID: 7157511
    [No Abstract]   [Full Text] [Related]  

  • 22. Directing the post-TEFRA laboratory.
    Sharp JW
    Pathologist; 1985 Feb; 39(2):15-8. PubMed ID: 10270443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathology practice under TEFRA and DRGs.
    Breckenridge RL
    Pathologist; 1983 Aug; 37(8):560-2. PubMed ID: 10310298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing ancillary services costs.
    Lamprey J
    Hosp Peer Rev; 1978 Oct; 3(10):140. PubMed ID: 10316719
    [No Abstract]   [Full Text] [Related]  

  • 25. Zero base approach to fiscal management of the laboratory.
    Boudreau DA; Majonos JS
    Pathologist; 1985 Aug; 39(8):14-8. PubMed ID: 10272519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hospital laboratory inventory management.
    Weinstein W; Wenk RE
    Clin Lab Med; 1985 Dec; 5(4):753-60. PubMed ID: 3936670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paying for diagnostic accuracy.
    Benfari MJ; Neuhauser D
    Health Care Manage Rev; 1976; 1(3):7-12. PubMed ID: 10316808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Benefits and costs of clinical chemical laboratory studies].
    van Kampen EJ
    Ned Tijdschr Geneeskd; 1979 Nov; 123(45):1941-4. PubMed ID: 117387
    [No Abstract]   [Full Text] [Related]  

  • 29. A cost containment checklist.
    Garcia LS
    MLO Med Lab Obs; 1985 Apr; 17(4):67-8, 71-5. PubMed ID: 10270788
    [No Abstract]   [Full Text] [Related]  

  • 30. Instituting change to cut lab costs.
    Pelton TN
    Pathologist; 1985 Jul; 39(7):17-20. PubMed ID: 10272022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost of unnecessary tests by day or night.
    Broughton PM
    Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1503-4. PubMed ID: 3111613
    [No Abstract]   [Full Text] [Related]  

  • 32. Acquisition alternatives for capital equipment.
    Burrows SB
    Pathologist; 1983 May; 37(5):326-8. PubMed ID: 10261179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospitals for radical new cost rules.
    MLO Med Lab Obs; 1983 Jan; 15(1):27-8. PubMed ID: 10298828
    [No Abstract]   [Full Text] [Related]  

  • 34. Future of the pathologist in an era of technological change and cost containment.
    Gray TA; Mcleod AJ; Bignell AHC
    Br Med J (Clin Res Ed); 1987 Apr; 294(6576):902-3. PubMed ID: 3105798
    [No Abstract]   [Full Text] [Related]  

  • 35. In-house software monitors and projects costs.
    Sealfon MS
    MLO Med Lab Obs; 1987 Jan; 19(1):75-6. PubMed ID: 10280455
    [No Abstract]   [Full Text] [Related]  

  • 36. The re-organization of hospital laboratories.
    Yahagi T
    Jpn Hosp; 1982 Jul; 1():45-8. PubMed ID: 10317265
    [No Abstract]   [Full Text] [Related]  

  • 37. Costs of tests.
    Abrams ME
    J R Coll Physicians Lond; 1979 Oct; 13(4):217-8. PubMed ID: 529211
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost containment in the clinical laboratory--to be or to seem to be, or when is a nontest a test?
    Lundberg GD; Westlake GE
    JAMA; 1980 Apr; 243(16):1659. PubMed ID: 7359758
    [No Abstract]   [Full Text] [Related]  

  • 39. Managing lab costs and utilization: balance supply and demand.
    Hardwick DF; Morrison JI; Cassidy PA
    Dimens Health Serv; 1985 Sep; 62(8):18-22. PubMed ID: 4076623
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of organ transplant program on the Clinical Chemistry Laboratory at the University of Pittsburgh.
    Sanghvi A
    Arch Pathol Lab Med; 1986 Feb; 110(2):95-7. PubMed ID: 3511883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.